PT3573948T - Métodos de preparação de derivados de benzodiazepina citotóxicos - Google Patents
Métodos de preparação de derivados de benzodiazepina citotóxicosInfo
- Publication number
- PT3573948T PT3573948T PT187043526T PT18704352T PT3573948T PT 3573948 T PT3573948 T PT 3573948T PT 187043526 T PT187043526 T PT 187043526T PT 18704352 T PT18704352 T PT 18704352T PT 3573948 T PT3573948 T PT 3573948T
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- benzodiazepine derivatives
- cytotoxic benzodiazepine
- preparing cytotoxic
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/19—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/16—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
- C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762450270P | 2017-01-25 | 2017-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3573948T true PT3573948T (pt) | 2023-01-11 |
Family
ID=61189535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT187043526T PT3573948T (pt) | 2017-01-25 | 2018-01-24 | Métodos de preparação de derivados de benzodiazepina citotóxicos |
Country Status (22)
Country | Link |
---|---|
US (4) | US10385071B2 (pt) |
EP (2) | EP4148044A1 (pt) |
JP (3) | JP7066725B2 (pt) |
KR (2) | KR102480594B1 (pt) |
CN (3) | CN116554262A (pt) |
AU (3) | AU2018213202B2 (pt) |
CA (1) | CA3050262A1 (pt) |
DK (1) | DK3573948T3 (pt) |
ES (1) | ES2935346T3 (pt) |
FI (1) | FI3573948T3 (pt) |
HR (1) | HRP20230002T1 (pt) |
HU (1) | HUE060746T2 (pt) |
IL (3) | IL293645A (pt) |
LT (1) | LT3573948T (pt) |
PL (1) | PL3573948T3 (pt) |
PT (1) | PT3573948T (pt) |
RS (1) | RS63871B1 (pt) |
RU (2) | RU2021138005A (pt) |
SG (1) | SG11201906666QA (pt) |
SI (1) | SI3573948T1 (pt) |
TW (3) | TWI763771B (pt) |
WO (1) | WO2018140435A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201906666QA (en) | 2017-01-25 | 2019-08-27 | Immunogen Inc | Methods of preparing cytotoxic benzodiazepine derivatives |
KR20210099010A (ko) * | 2018-11-12 | 2021-08-11 | 이뮤노젠 아이엔씨 | 세포독성 벤조디아제핀 유도체의 제조 방법 |
MA54228A (fr) | 2018-11-12 | 2021-09-22 | Immunogen Inc | Procédés de préparation de dérivés de benzodiazépine cytotoxiques |
TW202102506A (zh) * | 2019-03-29 | 2021-01-16 | 美商伊繆諾金公司 | 苯二氮平衍生物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9018601D0 (en) | 1990-08-24 | 1990-10-10 | Fujisawa Pharmaceutical Co | Tricyclic compounds |
NZ610939A (en) | 2010-12-21 | 2014-07-25 | Janssen Pharmaceutica Nv | Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]- benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with bicyclic benzene derivatives |
EP3666289A1 (en) * | 2011-02-15 | 2020-06-17 | ImmunoGen, Inc. | Cytotoxic benzodiazepine derivatives |
CA2973354A1 (en) | 2015-01-14 | 2016-07-21 | Bristol-Myers Squibb Company | Benzodiazepine dimers, conjugates thereof, and methods of making and using |
RU2739612C2 (ru) * | 2015-06-29 | 2020-12-28 | Иммуноджен, Инк. | Анти-cd123 антитела и их конъюгаты и производные |
PL3325482T3 (pl) | 2015-07-21 | 2021-01-11 | Immunogen, Inc. | Sposoby otrzymywania cytotoksycznych pochodnych benzodiazepiny |
SG11201906666QA (en) | 2017-01-25 | 2019-08-27 | Immunogen Inc | Methods of preparing cytotoxic benzodiazepine derivatives |
-
2018
- 2018-01-24 SG SG11201906666QA patent/SG11201906666QA/en unknown
- 2018-01-24 FI FIEP18704352.6T patent/FI3573948T3/fi active
- 2018-01-24 SI SI201830832T patent/SI3573948T1/sl unknown
- 2018-01-24 RS RS20221193A patent/RS63871B1/sr unknown
- 2018-01-24 DK DK18704352.6T patent/DK3573948T3/da active
- 2018-01-24 WO PCT/US2018/014956 patent/WO2018140435A1/en unknown
- 2018-01-24 CN CN202310124650.6A patent/CN116554262A/zh active Pending
- 2018-01-24 PT PT187043526T patent/PT3573948T/pt unknown
- 2018-01-24 JP JP2019540404A patent/JP7066725B2/ja active Active
- 2018-01-24 ES ES18704352T patent/ES2935346T3/es active Active
- 2018-01-24 TW TW107102506A patent/TWI763771B/zh active
- 2018-01-24 RU RU2021138005A patent/RU2021138005A/ru unknown
- 2018-01-24 TW TW112117953A patent/TW202400551A/zh unknown
- 2018-01-24 LT LTEPPCT/US2018/014956T patent/LT3573948T/lt unknown
- 2018-01-24 TW TW111114178A patent/TWI805325B/zh active
- 2018-01-24 KR KR1020197024738A patent/KR102480594B1/ko active IP Right Grant
- 2018-01-24 IL IL293645A patent/IL293645A/en unknown
- 2018-01-24 CN CN202310124604.6A patent/CN116102615A/zh active Pending
- 2018-01-24 US US15/878,991 patent/US10385071B2/en active Active
- 2018-01-24 IL IL287405A patent/IL287405B/en unknown
- 2018-01-24 KR KR1020227044421A patent/KR20230005410A/ko active IP Right Grant
- 2018-01-24 EP EP22199432.0A patent/EP4148044A1/en not_active Withdrawn
- 2018-01-24 AU AU2018213202A patent/AU2018213202B2/en active Active
- 2018-01-24 CN CN201880008141.4A patent/CN110225904B/zh active Active
- 2018-01-24 PL PL18704352.6T patent/PL3573948T3/pl unknown
- 2018-01-24 EP EP18704352.6A patent/EP3573948B1/en active Active
- 2018-01-24 HU HUE18704352A patent/HUE060746T2/hu unknown
- 2018-01-24 HR HRP20230002TT patent/HRP20230002T1/hr unknown
- 2018-01-24 RU RU2019125133A patent/RU2762891C2/ru active
- 2018-01-24 CA CA3050262A patent/CA3050262A1/en active Pending
-
2019
- 2019-06-17 US US16/442,718 patent/US10844078B2/en active Active
- 2019-07-22 IL IL268213A patent/IL268213B/en unknown
-
2020
- 2020-10-22 US US17/077,688 patent/US11390633B2/en active Active
-
2022
- 2022-03-07 AU AU2022201572A patent/AU2022201572B2/en active Active
- 2022-04-27 JP JP2022072946A patent/JP7400005B2/ja active Active
- 2022-06-15 US US17/841,026 patent/US11981687B2/en active Active
-
2023
- 2023-12-06 JP JP2023205788A patent/JP2024028860A/ja not_active Withdrawn
-
2024
- 2024-02-21 AU AU2024201119A patent/AU2024201119A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL268737A (en) | Processes for the preparation of benzodiapine derivatives | |
IL291598A (en) | History of benzodiazepine cytotoxicity | |
IL286788A (en) | Methods for the preparation of cytotoxic benzodiazepine compounds | |
IL287405A (en) | Methods for preparing cytotoxic benzodiazepine derivatives | |
IL293192A (en) | Methods for the preparation of indolinobenzodiazepine derivatives | |
IL283047A (en) | Methods for preparing cytotoxic benzodiazepine derivatives | |
IL283045A (en) | Methods for preparing cytotoxic benzodiazepine derivatives |